Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
CLLS
Deeply overvalued
Cellectis S.A.
Price$1.26
Model IV$0.95
P/IV1.64
Premium +32%
Return to IV: -24.4%
Market implies +3.5%/yr
vs model +24.5% · below model
CLM
Valuation N/A
Cornerstone Strategic Investment Fund, Inc.
Price$6.59
Model IV—
P/IV—
Limited data — see page
CLNN
Valuation N/A
Clene Inc.
Price$3.86
Model IV—
P/IV—
Market implies +90.3%/yr
CLPR
Deeply undervalued
Clipper Realty Inc.
Price$3.13
Model IV$12.27
P/IV0.26
Discount 74%
Return to IV: +292.1%
CLPS
Deeply undervalued
CLPS Inc
Price$1.01
Model IV$17.47
P/IV0.05
Discount 94%
Return to IV: +1,638.1%
Market implies -50.0%/yr
vs model +6.9% · below model
CLRB
Valuation N/A
Cellectar Biosciences, Inc.
Price$1.45
Model IV—
P/IV—
Limited data — see page
CLSKW
Deeply undervalued
CLEANSPARK, INC.
Price$0.21
Model IV$4.25
P/IV0.06
Discount 95%
Return to IV: +1,948.2%
Market implies -50.0%/yr
vs model +50.0% · below model
CLST
Deeply overvalued
Catalyst Bancorp, Inc.
Price$16.80
Model IV$11.44
P/IV1.58
Premium +47%
Return to IV: -31.9%
CLWT
Valuation N/A
EURO TECH HOLDINGS CO LTD
Price$1.36
Model IV—
P/IV—
Market implies +35.5%/yr
vs model +2.0% · above model
CMCT
Valuation N/A
Creative Media & Community Trust Corp
Price$3.87
Model IV—
P/IV—
Limited data — see page
CMII
Valuation N/A
Columbus Circle Capital Corp II
Price$10.05
Model IV—
P/IV—
Limited data — see page
CMIIU
Valuation N/A
CMIIU
Price$10.95
Model IV—
P/IV—
Limited data — see page
CMIIW
Valuation N/A
CMIIW
Price$0.72
Model IV—
P/IV—
Limited data — see page
CMND
Valuation N/A
Clearmind Medicine Inc.
Price$6.58
Model IV—
P/IV—
Limited data — see page
CMRC
Deeply undervalued
Commerce.com, Inc.
Price$3.48
Model IV$6.84
P/IV0.46
Discount 49%
Return to IV: +96.6%
Market implies -11.4%/yr
vs model +11.7% · below model
CMT
Deeply overvalued
CORE MOLDING TECHNOLOGIES INC
Price$23.27
Model IV$16.46
P/IV1.39
Premium +41%
Return to IV: -29.2%
Market implies +5.2%/yr
vs model +2.0% · above model
CMTG
Valuation N/A
Claros Mortgage Trust, Inc.
Price$1.20
Model IV—
P/IV—
Market implies +16.8%/yr
CMTL
Deeply undervalued
COMTECH TELECOMMUNICATIONS CORP /DE/
Price$1.18
Model IV$10.49
P/IV0.54
Discount 89%
Return to IV: +788.9%
Market implies -44.1%/yr
vs model +2.0% · below model
CMTV
Deeply overvalued
COMMUNITY BANCORP /VT
Price$43.20
Model IV$31.37
P/IV1.15
Premium +38%
Return to IV: -27.4%
CMU
Valuation N/A
MFS HIGH YIELD MUNICIPAL TRUST
Price$3.73
Model IV—
P/IV—
Limited data — see page
CNCK
Valuation N/A
Coincheck Group N.V.
Price$1.35
Model IV—
P/IV—
Limited data — see page
CNCKW
Valuation N/A
Coincheck Group N.V.
Price$0.22
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +37.6% · below model
CNDT
Valuation N/A
CONDUENT Inc
Price$1.60
Model IV—
P/IV—
Market implies -1.4%/yr
vs model +0.0% · in line
CNET
Deeply overvalued
ZW Data Action Technologies Inc.
Price$1.47
Model IV$0.95
P/IV0.70
Premium +54%
Return to IV: -35.2%
Market implies +2.9%/yr
vs model +2.0% · in line
CNEY
Valuation N/A
CN ENERGY GROUP. INC.
Price$0.49
Model IV—
P/IV—
Market implies +28.1%/yr
vs model +0.0% · above model
CNSP
Valuation N/A
CNS Pharmaceuticals, Inc.
Price$5.35
Model IV—
P/IV—
Limited data — see page
CNTB
Valuation N/A
Connect Biopharma Holdings Ltd
Price$0.87
Model IV—
P/IV—
Market implies +50.2%/yr
vs model +15.0% · above model
CNTN
Valuation N/A
Canton Strategic Holdings, Inc.
Price$2.11
Model IV—
P/IV—
Limited data — see page
CNTX
Valuation N/A
Context Therapeutics Inc.
Price$0.30
Model IV—
P/IV—
Limited data — see page
CNTY
Valuation N/A
CENTURY CASINOS INC /CO/
Price$0.86
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +10.2% · below model
CNVS
Deeply undervalued
Cineverse Corp.
Price$1.91
Model IV$23.45
P/IV0.10
Discount 92%
Return to IV: +1,127.9%
Market implies -25.4%/yr
vs model +24.3% · below model
CNXU
Valuation N/A
Conexeu Sciences Inc.
Price$3.89
Model IV—
P/IV—
Limited data — see page
COCH
Valuation N/A
Envoy Medical, Inc.
Price$0.66
Model IV—
P/IV—
Market implies +45.3%/yr
vs model +15.0% · above model
COCHW
Valuation N/A
Envoy Medical, Inc.
Price$0.04
Model IV—
P/IV—
Market implies +18.8%/yr
vs model +15.0% · above model
COCP
Valuation N/A
Cocrystal Pharma, Inc.
Price$1.07
Model IV—
P/IV—
Limited data — see page
CODA
Deeply overvalued
Coda Octopus Group, Inc.
Price$10.25
Model IV$6.38
P/IV1.96
Premium +61%
Return to IV: -37.7%
Market implies +9.2%/yr
vs model +5.8% · above model
CODX
Valuation N/A
Co-Diagnostics, Inc.
Price$1.12
Model IV—
P/IV—
Market implies +36.5%/yr
vs model +2.0% · above model
COHN
Deeply undervalued
Cohen & Co Inc.
Price$10.65
Model IV$26.69
P/IV0.41
Discount 60%
Return to IV: +150.6%
Market implies -4.4%/yr
vs model +14.4% · below model
COLA
Valuation N/A
Columbus Acquisition Corp/Cayman Islands
Price$2.86
Model IV—
P/IV—
Limited data — see page
COLAR
Valuation N/A
Columbus Acquisition Corp/Cayman Islands
Price$0.40
Model IV—
P/IV—
Limited data — see page
COLAU
Valuation N/A
Columbus Acquisition Corp/Cayman Islands
Price$3.78
Model IV—
P/IV—
Limited data — see page
COOK
Valuation N/A
Traeger, Inc.
Price$51.60
Model IV—
P/IV—
Market implies +44.7%/yr
vs model +2.0% · above model
COOT
Deeply undervalued
Australian Oilseeds Holdings Ltd
Price$0.44
Model IV$1.01
P/IV0.46
Discount 56%
Return to IV: +127.8%
Market implies -18.0%/yr
vs model +17.6% · below model
COOTW
Valuation N/A
Australian Oilseeds Holdings Ltd
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr
COPL
Valuation N/A
Copley Acquisition Corp
Price$10.57
Model IV—
P/IV—
Limited data — see page
CORN
Valuation N/A
Teucrium Commodity Trust
Price$18.42
Model IV—
P/IV—
Limited data — see page
COSM
Valuation N/A
Cosmos Health Inc.
Price$0.34
Model IV—
P/IV—
Market implies +13.3%/yr
COYA
Valuation N/A
Coya Therapeutics, Inc.
Price$4.95
Model IV—
P/IV—
Market implies +25.2%/yr
CPBI
Deeply overvalued
Central Plains Bancshares, Inc.
Price$20.00
Model IV$14.17
P/IV1.41
Premium +41%
Return to IV: -29.2%
CPF
Overvalued
CENTRAL PACIFIC FINANCIAL CORP
Price$35.60
Model IV$28.38
P/IV0.25
Premium +25%
Return to IV: -20.3%
CPHC
Deeply undervalued
Canterbury Park Holding Corp
Price$15.70
Model IV$28.65
P/IV0.55
Discount 45%
Return to IV: +82.5%
Market implies -7.1%/yr
vs model +3.0% · below model
CPHI
Deeply overvalued
CHINA PHARMA HOLDINGS, INC.
Price$0.87
Model IV$0.55
P/IV1.22
Premium +59%
Return to IV: -37.1%
Market implies +9.0%/yr
vs model +2.0% · above model
CPIX
Deeply overvalued
CUMBERLAND PHARMACEUTICALS INC
Price$7.03
Model IV$4.08
P/IV2.01
Premium +72%
Return to IV: -42.0%
Market implies +12.4%/yr
vs model +8.6% · above model
CPOP
Valuation N/A
Pop Culture Group Co., Ltd
Price$2.84
Model IV—
P/IV—
Market implies +38.4%/yr
vs model +25.0% · above model
CPSH
Valuation N/A
CPS TECHNOLOGIES CORP/DE/
Price$3.54
Model IV—
P/IV—
Market implies +14.8%/yr
vs model +9.8% · above model
CPSS
Valuation N/A
CONSUMER PORTFOLIO SERVICES, INC.
Price$9.38
Model IV—
P/IV—
Market implies -48.0%/yr
CPZ
Valuation N/A
Calamos Long/Short Equity & Dynamic Income Trust
Price$12.64
Model IV—
P/IV—
Limited data — see page
CRAC
Valuation N/A
Crown Reserve Acquisition Corp. I
Price$10.25
Model IV—
P/IV—
Limited data — see page
CRACR
Valuation N/A
Crown Reserve Acquisition Corp. I
Price$0.10
Model IV—
P/IV—
Limited data — see page
CRACU
Valuation N/A
Crown Reserve Acquisition Corp. I
Price$10.34
Model IV—
P/IV—
Limited data — see page
